394.69

1.25% 4.87

Elevance Health Inc (ELV)

Overview News Price History Option Chain Financials Why ELV Down? Discussions Forecast Stock Split Dividend History

Elevance Health Inc stock is traded at $394.69, with a volume of 1.09M. It is up +1.25% in the last 24 hours and up +20.26% over the past month. Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Previous Close:

$389.82

Open:

$393.64

24h Volume:

1.09M

Relative Volume:

0.57

Market Cap:

$85.71B

Revenue:

$200.42B

Net Income/Loss:

$5.24B

P/E Ratio:

16.79

EPS:

23.5042

Net Cash Flow:

$6.45B

1W Performance:

+0.51%

1M Performance:

+20.26%

6M Performance:

+22.68%

1Y Performance:

+2.65%

1-Day Range:

$392.02

$396.59

1-Week Range:

$385.05

$408.00

52-Week Range:

$273.71

$408.00

Elevance Health Inc Stock (ELV) Company Profile

Name

Elevance Health Inc

Sector

Healthcare (1108)

Industry

Healthcare Plans (12)

Phone

(800) 331-1476

Address

220 VIRGINIA AVENUE, INDIANAPOLIS

Employee

97,100

Twitter

Next Earnings Date

2026-07-16

Latest SEC Filings

ELV's Discussions on Twitter

Compare ELV vs UNH, CVS, CI, HUM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELV Elevance Health Inc	394.69	84.65B	200.42B	5.24B	6.45B	23.50
UNH Unitedhealth Group Inc	388.47	347.35B	449.71B	12.81B	19.67B	13.24
CVS Cvs Health Corp	93.26	119.07B	407.94B	2.90B	7.39B	2.2771
CI Cigna Group	286.24	74.60B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	307.95	36.46B	137.20B	1.15B	1.27B	9.3439

Elevance Health Inc Stock (ELV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-26	Initiated	Evercore ISI	In-line
Feb-03-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jan-08-26	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-19-25	Downgrade	Deutsche Bank	Buy → Hold
Oct-14-25	Initiated	Goldman	Neutral
Jul-21-25	Downgrade	Argus	Buy → Hold
Jul-18-25	Downgrade	Leerink Partners	Outperform → Market Perform
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-17-25	Upgrade	Argus	Hold → Buy
Jan-22-25	Downgrade	Stephens	Overweight → Equal-Weight
Oct-18-24	Downgrade	Argus	Buy → Hold
Jul-18-24	Downgrade	BofA Securities	Buy → Neutral
Jun-24-24	Initiated	Morgan Stanley	Overweight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-06-24	Initiated	Barclays	Overweight
Jul-12-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Mar-28-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Sep-09-22	Upgrade	BofA Securities	Neutral → Buy
Aug-22-22	Upgrade	SVB Leerink	Mkt Perform → Outperform

View All

Elevance Health Inc Stock (ELV) Latest News

May 23, 2026

What Elevance Health (ELV)'s Raised EPS Outlook and Insider Stock Sale Means For Shareholders - Yahoo Finance

May 23, 2026

May 22, 2026

Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

May 22, 2026

Elevance Health Price Target Raised to $460.00/Share From $400.00 by UBS - Moomoo

May 22, 2026

Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance

May 22, 2026

Are Wall Street Analysts Predicting Elevance Stock Will Climb or Sink? - Barchart.com

May 22, 2026

UBS Adjusts Price Target on Elevance Health to $460 From $400, Maintains Buy Rating - marketscreener.com

May 22, 2026

May 21, 2026

Elevance executive ordered to testify in Medicare Advantage fraud case - statnews.com

May 21, 2026

May 20, 2026

Elevance Health CAO Ronald Penczek sells $617,192 of company stock - Investing.com

May 20, 2026

Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch

May 20, 2026

Elevance Health Insider Sold Shares Worth $617,192, According to a Recent SEC Filing - marketscreener.com

May 20, 2026

Elevance Health (NYSE: ELV) CAO exercises options, sells 1,531 shares - Stock Titan

May 20, 2026

Elevance Health Is Maintained at Outperform by Mizuho - Moomoo

May 20, 2026

Deutsche Bank Upgrades Elevance Health to Buy From Hold, Adjusts PT to $498 From $363 - marketscreener.com

May 20, 2026

Mizuho Adjusts Price Target on Elevance Health to $435 From $385, Maintains Outperform Rating - marketscreener.com

May 20, 2026

May 19, 2026

ELV (NYSE: ELV) Form 144 filed for 1,531 shares on 05/19/2026 - Stock Titan

May 19, 2026

How providers are responding to Elevance’s out-of-network policy - Modern Healthcare

May 19, 2026

May 18, 2026